MindWalk Holdings Corp. (HYFT)
NASDAQ: HYFT · Real-Time Price · USD
1.110
-0.020 (-1.77%)
Nov 2, 2026, 12:14 PM EST - Market open
Company Description
MindWalk Holdings Corp. operates as a bio-native AI company.
The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology.
The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025.
The company is headquartered in Austin, Texas.
MindWalk Holdings Corp.
| Country | United States |
| Founded | 1983 |
| IPO Date | Jan 3, 2017 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 77 |
| CEO | Jennifer Bath |
Contact Details
Address: Industrious 823 Congress Ave, Suite 300 Austin, Texas 78701 United States | |
| Phone | 800 620 4187 |
| Website | mindwalkai.com |
Stock Details
| Ticker Symbol | HYFT |
| Exchange | NASDAQ |
| Fiscal Year | May - April |
| Reporting Currency | CAD |
| CIK Code | 1715925 |
| CUSIP Number | 602687105 |
| ISIN Number | CA6026871054 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jennifer Lynne Bath Ph.D. | Chief Executive Officer, President and Non-Independent Director |
| Richard Scott Areglado | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 30, 2026 | 6-K/A | Filing |
| Oct 28, 2026 | 6-K | Report of foreign issuer |
| Oct 22, 2026 | 6-K | Report of foreign issuer |
| Oct 21, 2026 | 6-K | Report of foreign issuer |
| Oct 14, 2026 | 6-K | Report of foreign issuer |
| Oct 6, 2026 | 6-K | Report of foreign issuer |
| Oct 1, 2026 | 6-K | Report of foreign issuer |
| Sep 21, 2026 | 6-K | Report of foreign issuer |
| Sep 21, 2026 | 6-K | Report of foreign issuer |
| Sep 14, 2026 | 6-K | Report of foreign issuer |